Treatment of Dyshidrotic Eczema
For dyshidrotic eczema, the first-line treatment is high-potency topical corticosteroids for short periods, followed by medium to low-potency options for maintenance, with PUVA therapy or alitretinoin considered for severe or recalcitrant cases. 1
First-Line Treatment Options
Topical Therapies
Topical corticosteroids:
- Use high-potency topical corticosteroids for short periods (2-4 weeks) on thickened areas in severe cases 1
- Apply medium-potency topical corticosteroids once daily for mild to moderate cases 1
- Use low-potency topical corticosteroids for sensitive areas like the face 1
- Once-daily application of potent topical corticosteroids is as effective as twice-daily application 2
Emollients and moisturizers:
Topical calcineurin inhibitors:
Second-Line Treatment Options
Phototherapy
- PUVA (Psoralen plus UVA) therapy:
- Oral PUVA has been shown to be superior to UVB for hand eczema 4
- Oral PUVA can achieve significant improvement or clearance in 81-86% of patients with hand and foot eczema 4
- Topical PUVA has shown variable results with improvement rates of 58-81% in uncontrolled studies, but less convincing evidence in comparative studies 4
Systemic Treatments
- Alitretinoin:
- Recommended for chronic or recalcitrant cases 1
- Particularly effective for severe hand eczema that doesn't respond to topical treatments
Management of Secondary Complications
Bacterial infections:
Severe itching:
- Consider oral antihistamines such as cetirizine, loratadine, or fexofenadine 1
Prevention and Maintenance
Trigger identification and avoidance:
Proactive maintenance therapy:
Treatment Algorithm for Dyshidrotic Eczema
Acute phase:
- High-potency topical corticosteroids once daily for 2-4 weeks
- Liberal use of emollients
- Avoid identified triggers
If inadequate response or severe disease:
Maintenance phase:
- Weekend (proactive) application of topical corticosteroids
- Daily emollients
- Rotational therapy with topical tacrolimus may be beneficial 3
Important Caveats and Pitfalls
Corticosteroid-related concerns:
- Avoid prolonged use of potent topical corticosteroids due to risk of skin thinning 2
- Risk of developing side effects depends on potency, duration of use, and volume applied 5
- Clobetasol propionate (very potent) should be limited to maximum 2 weeks of use 5
- Be aware of the cumulative depot effect of potent corticosteroids 5
Efficacy considerations:
Treatment resistance:
- For cases refractory to multiple forms of topical and systemic agents, low-dose radiation therapy has shown complete resolution in some cases, though this is not a first-line approach 7